SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HBOC...Buy in here?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mun who wrote (227)8/12/1998 1:19:00 AM
From: Rarebird  Read Replies (1) of 341
 
Good Post. Yes, the Inmet acquisition was a good one. But the CEO of HBOC should have explained the rationale behind the proposed merger with Mckesson before letting the Market determine his hand. Manipulating expectations is crucial. The Market drew its own conclusions and who was there to reassure it or ally its fears of slower growth. On the other hand, the market wanted to interpret this failed merger in a bearish manner. It was a good excuse to sell. Still, a tactical PR error: lack of clarification causes uncertainty. Uncertainty is devastating for shareholders.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News